Long-term treatment of sulphonylurea-treated diabetics with the alpha-glucosidase inhibitor Bay g 5421 (acarbose)
D020909:Acarbose; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008875:Middle Aged; D009844:Oligosaccharides / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014312:Trisaccharides / Q000627:therapeutic use*
D009844:Oligosaccharides; D013453:Sulfonylurea Compounds; D014312:Trisaccharides; D020909:Acarbose